Evidence map›Paper›PMID 37476067›Full record

ArticleBioengineering & translational medicine2023

The combination of resveratrol and

Tzu-Chieh Lin, Jhih-Ni Lin, I-Hsuan Yang, Christina Soong, Ya-Jyun Liang, Subhaini Jakfar, Chun-Che Yen, Hwa-Chang Liu, Hsuan-Yu Chen, Feng-Huei Lin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioengineering & translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Biomacromolecules · 2024
    Article
  5. The combination of resveratrol andBioengineering & translational medicine · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Tzu-Chieh LinDepartment of Biomedical Engineering, College of Medicine and College of Engineering National Taiwan University Taipei Taiwan.
Jhih-Ni LinDepartment of Biomedical Engineering, College of Medicine and College of Engineering National Taiwan University Taipei Taiwan.
I-Hsuan YangDepartment of Biomedical Engineering, College of Medicine and College of Engineering National Taiwan University Taipei Taiwan.
Christina SoongDepartment of Biomedical Engineering, College of Medicine and College of Engineering National Taiwan University Taipei Taiwan.
Ya-Jyun LiangDepartment of Biomedical Engineering, College of Medicine and College of Engineering National Taiwan University Taipei Taiwan.
Subhaini JakfarDepartment of Biomedical Engineering, College of Medicine and College of Engineering National Taiwan University Taipei Taiwan.
Chun-Che YenKartigen Biomedical Inc. Taipei Taiwan.
Hwa-Chang LiuDepartment of Orthopaedic Surgery Taiwan Adventist Hospital Taipei Taiwan.
Hsuan-Yu ChenDepartment of Biomedical Engineering, College of Medicine and College of Engineering National Taiwan University Taipei Taiwan.ORCID https://orcid.org/0000-0003-4998-7566
Feng-Huei LinDepartment of Biomedical Engineering, College of Medicine and College of Engineering National Taiwan University Taipei Taiwan.ORCID https://orcid.org/0000-0002-2994-6671
National Taiwan University · TWNational Health Research Institutes · TWTaiGen Biotechnology (Taiwan) · TWTaiwan Adventist Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) of the knee is characterized by progressive deterioration and loss of articular cartilage with associatedstructural and performance changes in the entire joint, and current treatments for OA only aim to relieve symptoms, rather than to prevent or reverse disease progression. Recently, treatments targeting "early osteoarthritis" (EOA) have attracted attention. However, during EOA stage, chondrocytes may change behaviors to express pro-inflammatory cytokines and free radicals, which would cause detrimental effects to the synovial cavity and further cartilage wear. In this study, we combined resveratrol (Res) and

Indexed as

articular cartilageBletilla striatachondrocytesinflammationosteoarthritisoxidative stressresveratrol

Identifiers

PMID37476067
PMCPMC10354757
OpenAlexW4307649173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.